Keyphrases
Meta-analysis
100%
Pulmonary Hypertension
100%
World Health Organization
100%
Chronic Use
100%
Systematic Meta-analysis
100%
Pulmonary Arterial Hypertension-targeted Therapy
100%
Placebo
25%
Randomized Controlled Trial
25%
Confidence Interval
18%
6-minute Walk Distance (6MWD)
18%
Hypertension Patients
12%
Clinical Trials
6%
Pulmonary Arterial Hypertension
6%
Treatment Strategy
6%
Acute Exacerbation of COPD (AECOPD)
6%
Interstitial Lung Disease
6%
Single-arm Study
6%
Metaanalysis
6%
Exercise Capacity
6%
Specific Treatment
6%
Hypoxemia
6%
Beneficial Effects
6%
Pulmonary Artery Pressure
6%
MEDLINE
6%
Embase
6%
Symptom Burden
6%
Pulmonary Vascular Resistance
6%
Random Effects
6%
Medical Costs
6%
Single-arm Clinical Trial
6%
Number of Patients
6%
Nursing and Health Professions
Systematic Review
100%
Meta Analysis
100%
World Health Organization
100%
Pulmonary Hypertension
100%
Obstructive Lung Disease
21%
Placebo
17%
Walking Distance
13%
Confidence Interval
13%
Lung Artery Pressure
4%
Hypoxemia
4%
Lung Vascular Resistance
4%
Interstitial Lung Disease
4%
Medicine and Dentistry
Systematic Review
100%
Pulmonary Hypertension
100%
Meta-Analysis
100%
Chronic Obstructive Pulmonary Disease
21%
Randomized Controlled Trial
17%
Placebo
17%
Clinical Trial
8%
Arm
8%
Health Care Cost
4%
Interstitial Lung Disease
4%
Clinician
4%
Lung Artery Pressure
4%
Hypoxemia
4%
Lung Vascular Resistance
4%
Exercise
4%
Immunology and Microbiology
Arm
100%
Exercise
50%
Lung Vascular Resistance
50%
Lung Artery Pressure
50%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
Chronic Obstructive Lung Disease
21%
Randomized Controlled Trial
17%
Placebo
17%
Clinical Trial
8%
Hypoxemia
4%
Interstitial Lung Disease
4%